ZVRA Similar Chart Price Prediction
The price of ZVRA is predicted to go up -3.91%, based on the high correlation periods with BDJ. The similarity of these two price pattern on the periods is 92.48%.
ZVRA
BDJ
Down: -3.91%Similarity: 92.48%
ZVRA Revenue Forecast
ZVRA EPS Forecast
ZVRA FAQs
What is ZVRA revenue forecast for next quarter？
ZVRA Analyst's Forecast
Sumant Kulkarni
Canaccord Genuity
Strong Buy
2024-11-14
Price Target
$25 → $23
Upside
+154.71%
Canaccord lowered the firm's price target on Zevra Therapeutics to $23 from $25 and keeps a Buy rating on the shares. The firm noted they reported results with the key updates that the company had received 90 prescription (Rx) enrollment forms for Miplyffa (arimoclomol) for Niemann-Pick Type C (NPC)as of October 31, of which 30% are approved for reimbursement on an imminent launch of the product.
Jason Butler
JMP Securities
Buy
2024-09-24
Price Target
$17
Upside
+105.56%
Jonathan Aschoff
Roth MKM
Strong Buy
2024-09-24
Price Target
$19 → $21
Upside
+153.93%
